6-OHDA lesion in medial forebrain bundle

By Santiago Unda, MD, Mihaela Stavarache, Michael Kaplitt, MD, PhD and Roberta Marongiu, PhD
View Published Protocol

Output Details

Description
Lesion of the medial forebrain bundle using 6-OHDA to induce parkinsonian-like deficits in mice.
Identifier (DOI)
10.17504/protocols.io.8epv5r9o4g1b/v1
Tags
  • 6-OHDA
  • Animal
  • In Vivo
  • Medial forebrain bundle
  • Motor symptoms
  • Mouse
Team
Team Kaplitt
Program
Collaborative Research Network
Theme
Circuitry and Brain-Body Interactions

Meet the Authors

Related Research

Phosphoglycerate kinase is a central leverage point in Parkinson’s disease–driven neuronal metabolic deficits

Study shows increasing PGK1 gene expression enhances neuronal ATP production, protecting against synaptic dysfunction in Parkinson's disease. Boosting bioenergetics with PGK1 may be a promising therapeutic approach for PD.

View Article

6-OHDA mouse model of Parkinson’s disease

Protocol for creating a Parkinson's disease mouse model using 6-OHDA involves injecting different doses into the brain to induce varying levels of dopaminergic damage.

View Protocol

Levodopa treatment for low-dose 6-OHDA-treated mice

This protocol describes a one-week levodopa treatment for mice partially depleted of dopamine.

View Protocol
View More Outputs